Antiretroviral Medications - Bictegravir/Emtricitabina/Tenofovir (3 months)

Summary

This is a contract award notice for the supply of antiretroviral pharmaceutical products containing bictegravir 50mg, emtricitabina 200mg, and tenofovir alafenamida 25mg tablets. The contract was awarded to Gilead Sciences, Lda for a 3-month supply period to Serviços de Saúde da Região Autónoma da Madeira (SESARAM) in Funchal, Portugal. The estimated contract value is €370,411.92 excluding VAT. This was a restricted procedure with one tender received and awarded on 26 August 2026.